Assessing Denka (TSE:4061) Valuation After Earnings Show Higher Profitability On Softer Sales

Simply Wall St

Tue, February 17, 2026 at 3:10 PM GMT+9 4 min read

Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million individual investors worldwide.

Earnings event puts Denka (TSE:4061) profitability in focus

Denka (TSE:4061) reported earnings for the nine months to December 31, 2025, with sales of ¥290,774 million, compared with ¥301,598 million a year earlier. Net income rose to ¥5,535 million from ¥2,577 million.

See our latest analysis for Denka.

At a share price of ¥3,098, Denka has a 90 day share price return of 30.86% and a 1 year total shareholder return of 54.00%, suggesting momentum has strengthened recently even though the 5 year total shareholder return of a 9.16% decline shows a weaker longer term picture.

If these earnings have you thinking about where else profit improvements might show up next, it could be worth scanning our list of solid balance sheet and fundamentals stocks screener (35 results) as another starting point for ideas.

With earnings per share up over the period and the share price already strong over the past year, the key question now is simple: are you looking at an undervalued turnaround, or a market that already prices in future growth?

Preferred Price-to-Sales of 0.7x: Is it justified?

On the latest close at ¥3,098, Denka is trading on a P/S of 0.7x, which appears in line with the JP Chemicals industry average, but slightly above the peer group the model uses for comparison.

The P/S ratio compares the company’s market value to its revenue, so you are effectively paying 0.7 times annual sales for each share. For a business that is currently loss making, as Denka is, this metric can be a straightforward way to consider what the market is willing to pay for its existing sales base while profit recovery remains in progress.

Here, the signals are mixed. On one side, Denka’s 0.7x P/S sits a touch above the 0.6x peer average, which indicates investors are paying a premium to similar names. On the other side, the estimated fair P/S of 0.8x suggests some headroom if the market price eventually aligns with the level that regression analysis indicates could be more typical for its fundamentals.

This combination, trading a little richer than peers but below the fair P/S estimate, points to a market that is cautious but not excessively stretched on sales, particularly with earnings still in loss territory and expected to improve from there.

Explore the SWS fair ratio for Denka

Result: Preferred multiple of Price-to-Sales of 0.7x (ABOUT RIGHT)

However, you still have to weigh the current net income loss of ¥9,342 million and a 5 year total shareholder return decline of 9.16% against any turnaround hopes.

Story Continues  

Find out about the key risks to this Denka narrative.

Another view using our DCF model

There is a twist when you look at our DCF model. At ¥3,098, Denka trades above our estimate of future cash flow value of ¥1,215.54, which points to an overvalued picture rather than the roughly in line P/S story. So which signal matters more for you?

Look into how the SWS DCF model arrives at its fair value.

4061 Discounted Cash Flow as at Feb 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Denka for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 19 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If this mix of signals feels balanced on a knife edge, take a moment to review the details yourself, then move quickly to shape your own view by checking the 1 key reward and 2 important warning signs.

Looking for more investment ideas?

If you stop at Denka, you could miss other opportunities. Use this earnings update as a springboard and keep building out your watchlist with fresh ideas.

Target potential mispricings by reviewing our list of 19 high quality undervalued stocks that pair solid fundamentals with attractive entry points.

Strengthen your portfolio’s foundation by checking companies in the 48 resilient stocks with low risk scores that score well on stability and business quality.

Get ahead of the crowd by scanning a screener containing 62 high quality undiscovered gems that the broader market may not be paying attention to yet.

_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

Companies discussed in this article include 4061.T.

Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email editorial-team@simplywallst.com_

Terms and Privacy Policy

Privacy Dashboard

More Info